Valuation: FDC Limited

Market Cap 52.29B 546M 479M 444M 408M 772M 787M 5.29B 2.07B 25.68B 2.05B 2.01B 88.69B P/E 2024
22.8x
P/E 2025 24.1x
Enterprise Value 47.15B 493M 432M 400M 368M 696M 710M 4.77B 1.87B 23.15B 1.85B 1.81B 79.95B EV / Sales 2024
3.32x
EV / Sales 2025 2.8x
Free-Float
30.05%
Yield 2024 *
-
Yield 2025 1.27%
1 day-0.81%
1 week-1.10%
Current month+1.20%
1 month+10.47%
3 months+21.89%
6 months+7.58%
Current year+1.23%
1 week 416.4
Extreme 416.4
442
1 month 379.15
Extreme 379.15
442
Current year 314.75
Extreme 314.75
442
1 year 314.75
Extreme 314.75
528.3
3 years 314.75
Extreme 314.75
659
5 years 229.15
Extreme 229.15
659
10 years 148.2
Extreme 148.2
659
Manager TitleAgeSince
Chief Executive Officer 90 2009-11-18
Chief Executive Officer 63 1993-09-29
Director of Finance/CFO - 2025-10-23
Director TitleAgeSince
Director/Board Member 48 2001-12-31
Director/Board Member 63 1993-09-29
Chairman 90 2009-11-15
Change 5-day change 1-year change 3-year change Capi.($)
-0.81%-1.10%-14.45%+32.38% 737M
-0.28%-0.82%+48.90%+173.81% 1,060B
+0.27%-0.58%+64.40%+62.34% 619B
-0.53%-3.05%+28.96%+84.89% 438B
-1.75%-0.33%+28.33%+23.58% 333B
+0.24%-0.42%+29.19%+47.26% 282B
-1.75%-10.57%+18.27%+22.07% 267B
+0.67%+1.03%-26.81%-37.96% 218B
-1.29%-2.05%+20.84%+57.66% 196B
+0.93%+1.23%+17.05%+71.03% 161B
Average -0.37%-3.03%+21.47%+53.71% 357.46B
Weighted average by Cap. -0.30%-3.09%+35.77%+84.36%

Financials

2024 2025
Net sales 19.43B 203M 178M 165M 152M 287M 293M 1.97B 771M 9.54B 762M 746M 32.95B 21.08B 220M 193M 179M 165M 311M 317M 2.13B 836M 10.35B 827M 809M 35.75B
Net income 3.05B 31.89M 27.97M 25.91M 23.84M 45.09M 45.96M 309M 121M 1.5B 120M 117M 5.18B 2.67B 27.87M 24.45M 22.64M 20.83M 39.41M 40.17M 270M 106M 1.31B 105M 102M 4.52B
Net Debt -4.55B -47.53M -41.69M -38.61M -35.53M -67.2M -68.51M -460M -180M -2.23B -178M -175M -7.72B -5.15B -53.8M -47.19M -43.71M -40.22M -76.07M -77.55M -521M -204M -2.53B -202M -198M -8.73B
Logo FDC Limited
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
Employees
6,857
Date Price Change Volume
26-07-13 428.50 -0.81% 4,041
26-07-10 ₹432.00 +0.03% 7,299
26-07-09 ₹431.85 +2.65% 14,522
26-07-08 ₹420.70 -1.26% 6,771
26-07-07 ₹426.05 -0.91% 6,083
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B